SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15170367
Source:
http://linkedlifedata.com/resource/pubmed/id/15170367
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0201734
,
umls-concept:C0205179
,
umls-concept:C0442117
,
umls-concept:C0935916
,
umls-concept:C1979963
,
umls-concept:C2003903
pubmed:issue
8
pubmed:dateCreated
2004-6-1
pubmed:abstractText
To characterise the pharmacokinetics of a long-acting formulation of fulvestrant following intramuscular administration of single and multiple doses.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7606849
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol
,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
pubmed:status
MEDLINE
pubmed:issn
0312-5963
pubmed:author
pubmed-author:ClarkeDavid ADA
,
pubmed-author:ComeSteven ESE
,
pubmed-author:EriksteinBjornB
,
pubmed-author:GertlerStanS
,
pubmed-author:HarrisonMike PMP
,
pubmed-author:OsborneKent CKC
,
pubmed-author:ParkerLeroy MLM
,
pubmed-author:PippenJohnJ
,
pubmed-author:RobertsonJohn F RJF
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
529-38
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15170367-Adult
,
pubmed-meshheading:15170367-Aged
,
pubmed-meshheading:15170367-Antineoplastic Agents, Hormonal
,
pubmed-meshheading:15170367-Area Under Curve
,
pubmed-meshheading:15170367-Breast Neoplasms
,
pubmed-meshheading:15170367-Double-Blind Method
,
pubmed-meshheading:15170367-Estradiol
,
pubmed-meshheading:15170367-Estrogen Antagonists
,
pubmed-meshheading:15170367-Female
,
pubmed-meshheading:15170367-Half-Life
,
pubmed-meshheading:15170367-Humans
,
pubmed-meshheading:15170367-Metabolic Clearance Rate
,
pubmed-meshheading:15170367-Middle Aged
,
pubmed-meshheading:15170367-Postmenopause
pubmed:year
2004
pubmed:articleTitle
Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
pubmed:affiliation
Nottingham City Hospital, Nottingham, UK.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III